These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 522183)

  • 1. Propylthiouracil and hepatitis: a case report.
    Reddy CM
    J Natl Med Assoc; 1979 Dec; 71(12):1185-6. PubMed ID: 522183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis associated with propylthiouracil treatment.
    Garty BZ; Kauli R; Ben-Ari J; Lubin E; Nitzan M; Laron Z
    Drug Intell Clin Pharm; 1985 Oct; 19(10):740-2. PubMed ID: 4053978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fulminant hepatitis and lymphocyte sensitization due to propylthiouracil.
    Mihas AA; Holley P; Koff RS; Hirschowitz BI
    Gastroenterology; 1976 May; 70(5 PT.1):770-4. PubMed ID: 1261772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propylthiouracil-induced hepatic damage.
    Ozenírler S; Tuncer C; Boztepe U; Akyol G; Alkim H; Cakir N; Kandílć U
    Ann Pharmacother; 1996 Sep; 30(9):960-3. PubMed ID: 8876856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute cholestatic hepatitis induced by propylthiouracil. Case report].
    Parolin MB; Lopes RW; Telles JE; Ioshii SO; Hajar N
    Arq Gastroenterol; 2000; 37(2):129-32. PubMed ID: 11144016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Major adverse reactions to propylthiouracil in 586 cases of hyperthyroidism].
    Frenkel J; Téllez R; Reyes C; González G; Michaud P
    Rev Med Chil; 1993 Nov; 121(11):1289-94. PubMed ID: 8191137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Liver involvement in propylthiouracil treatment of juvenile thyrotoxicosis].
    Jacobsen BB
    Ugeskr Laeger; 1979 Nov; 141(46):3171-2. PubMed ID: 524495
    [No Abstract]   [Full Text] [Related]  

  • 8. [A case of insulin autoimmune syndrome with cholestatic hepatitis induced by methimazole and propylthiouracil].
    Kimura T; Shindo T
    Nihon Naika Gakkai Zasshi; 1982 May; 71(5):685-91. PubMed ID: 7130811
    [No Abstract]   [Full Text] [Related]  

  • 9. Propylthiouracil and hepatitis. Two cases and a review of the literature.
    Hanson JS
    Arch Intern Med; 1984 May; 144(5):994-6. PubMed ID: 6608933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propylthiouracil hepatotoxicity. A review and case presentation.
    Levy M
    Clin Pediatr (Phila); 1993 Jan; 32(1):25-9. PubMed ID: 8419095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: Hepatitis and propylthiouracil.
    Parker LN
    Ann Intern Med; 1975 Feb; 82(2):228-9. PubMed ID: 1172923
    [No Abstract]   [Full Text] [Related]  

  • 12. [The clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism].
    Lian XL; Bai Y; Dai WX; Jin ZM; Zeng ZP; Guo ZS
    Zhonghua Nei Ke Za Zhi; 2004 Jun; 43(6):442-6. PubMed ID: 15312442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Propylthiouracil-induced overt hepatic injury in patients with hyperthyroidism].
    Lian XL; Bai Y; Dai WX; Guo ZS; Li W; Lu L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):172-7. PubMed ID: 15171556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence and clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism: a single-center retrospective study.
    Kim HJ; Kim BH; Han YS; Yang I; Kim KJ; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
    Am J Gastroenterol; 2001 Jan; 96(1):165-9. PubMed ID: 11197248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propylthiouracil-induced fulminant hepatitis: case report and review of the literature.
    Deidiker R; deMello DE
    Pediatr Pathol Lab Med; 1996; 16(5):845-52. PubMed ID: 9025882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propylthiouracil-associated hepatitis.
    Peter SA
    J Natl Med Assoc; 1991 Jan; 83(1):75-7. PubMed ID: 1994070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver disease caused by propylthiouracil.
    Fedotin MS; Lefer LG
    Arch Intern Med; 1975 Feb; 135(2):319-21. PubMed ID: 1147734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperthyroidism and propylthiouracil-induced agranulocytosis during chronic lithium carbonate therapy.
    Valenta LJ; Elias AN; Weber DJ
    Am J Psychiatry; 1981 Dec; 138(12):1605-7. PubMed ID: 6795944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic injury during propylthiouracil therapy in patients with hyperthyroidism. A cohort study.
    Liaw YF; Huang MJ; Fan KD; Li KL; Wu SS; Chen TJ
    Ann Intern Med; 1993 Mar; 118(6):424-8. PubMed ID: 8439116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propylthiouracil-induced hepatic damage.
    Weiss M; Hassin D; Bank H
    Arch Intern Med; 1980 Sep; 140(9):1184-5. PubMed ID: 6893265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.